Diverse Package Options Choose from a wide range of packages to fit your preferences
Autism Dev
Real-world data with behavioural support Second Natures peer-reviewed research, published in JMIR Formative Research (2025), showed that semaglutide, combined with registered dietitian support and a structured behaviour change programme, produced an average 19.1% weight loss at 12 months, with 77.7% of participants achieving at least 10% weight loss
Retatrutide reaches maintenance faster than tirzepatide
The BMI cutoff was chosen to best assess the primary endpoint (time in range, that is, glycemic control) through several hypothetical mechanisms of semaglutide, while reducing the risk of participants becoming underweight
Although there is no absolute contraindication to using both medications together, their opposing metabolic effectsparticularly on appetite, weight, and blood glucoserequire careful monitoring and individualised management